期刊文献+

肝癌相关抗原Kinectin的多克隆抗体制备、鉴定及初步应用 被引量:5

Preparation and identification of a polyclonal antibody to hepatocellular carcinoma associated antigen Kinectin
下载PDF
导出
摘要 目的制备本课题组报告的肝癌相关抗原Kinectin的多克隆抗体,并鉴定其免疫学特性。方法以本课题组前期构建的人MBP-Kinectin融合片段重组质粒为基础,原核表达和亲和层析大量纯化MBP-Kinectin融合蛋白,并免疫新西兰兔制备多克隆抗体;用间接ELISA法测定抗体效价,用Western blot鉴定抗体的特异性。同时用Kinectin多克隆抗体检测Kinectin在正常成人肝细胞HL-7702和人肝癌细胞株SMMC-7721内的表达。结果通过免疫新西兰兔获得抗Kinectin抗体,ELISA测定纯化的Kinectin抗体效价最高为1∶12 800,Western blot结果显示Kinectin抗体具有较好的特异性。免疫细胞化学和western blot检测发现Kinectin蛋白在肝癌细胞株内的表达显著高于正常成人肝细胞株。结论制备的抗Kinectin抗体具有较高的效价和特异性,能满足Western blot和免疫细胞化学检测Kinectin蛋白的要求,为进一步深入研究Kinectin在肝癌发生发展中的作用奠定基础。 This paper aimed to prepare the polyclonal antibodies against hepatocellular carcinoma associated antigen Kinectin,and identify the immune characteristic of anti-kinectin polyclonal antibody.We purified the MBP fusion protein MBP-kinectin from prokaryotic expression system constructed in our previous work.Then the polyclonal antibodies to MBP-kinectin were prepared by immunizing New Zealand rabbits with the purified fusion protein MBP-kinectin.The titer and specificity of the antibody were determined by ELISA and Western blot respectively.ELISA detection results showed that the titer of anti-kinectin polyclonal antibody was about 1∶128 000,while Western blot results showed that the polyclonal antibody to kinectin could bind to MBP-kinectin fusion protein specifically.Furthermore,the expression.of kinectin in hepatic cell HL-7702 and hepatocellular carcinoma cell SMMC-7721 were assayed both by immunohistochemistry technique and Western blot.We found that the protein expression of kinectin,which mainly present in the cytoplasmic area,was higher in hepatocellular carcinoma cell SMMC-7721 than in normal hepatic cell HL-7702.All results showed that polyclonal antibodies to kinectin are successfully preparation and can be applied to Western blot and immunohistochemistry.This work also lays a foundation for further exploring of the role of kinectin in the development of hepatocellular carcinoma.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第1期33-36,共4页 Immunological Journal
基金 广西自然科学基金重点项目(2010GXNSFD013048) 广西高校人才小高地建设创新团队资助计划(BGXZ2007010)
关键词 多克隆抗体 肝细胞癌 肿瘤相关抗原 KINECTIN Polyclonal antibody Tumor associated antigen Hepatocellular carcinoma Kinectin
  • 相关文献

参考文献9

  • 1Toyoshima I, Yu H, Steuer ER, et al. Kinectin, a major kinesin-binding protein on ER[J]. The Journal of Cell Biology, 1992, 118 (5): 1121-1131.
  • 2Print CG, Leung E, Harrison JE, et al. Cloning of a gene encoding a human leukocyte protein characterised by extensive heptad repeats[J]. Gene, 1994, 144(2):221-228.
  • 3Stenner LF, Luo GR, Sahin U, et al. Definition of Tumor-associated Antigens in Hepatocellular Carcinoma. Cancer Epidemiology [J]. Biomarkers & Prevention, 2000, 9 (3): 285-290.
  • 4黄天明,黄绍明,莫发荣,何少健,周素芳,邓琼英,李松峰,黄敏丽,李山,薛慧琴,梁皓,范容,闫磊,谢小薰,罗国容.肝癌相关抗原kinectin基因片断的重组表达[J].广西医科大学学报,2006,23(3):345-348. 被引量:14
  • 5史继静,刘朝奇,李斌,汪锦江,陈晶.HIV-1蛋白酶基因的克隆、蛋白表达及抗体制备[J].免疫学杂志,2010,26(2):116-119. 被引量:2
  • 6Ong LL, Angeline PL, Connie PN, et al. Kinectin-Kinesin Binding Domains and Their Effects on Organelle Motility[J]. The Journal Of Biological Chemistry, 2000, 275 (42): 32854-32860.
  • 7Vignal E, Blangy A, Martin M, et al. Kinectin Is a Key Effector of RhoG Microtubule-Dependent Cellular [J]. Activity Molecular And Cellular Biology, 2001, 21 (23): 8022-8034.
  • 8Ong LL, Lin PC, Zhang X, et al. Kinectin-dependent Assembly of Translation Elongation Factor-1 Complex on Endoplasmic Reticulum Regulates Protein Synthesis [J]. The Journal of Biological Chemistry, 2006, 281 (44): 33621-33634.
  • 9谢小薰,王延伟,黎鹏,蓝玲,赵飞兰,莫发荣,范容,罗国容.肝细胞癌相关抗原kinectin的血清学分析[J].科学技术与工程,2003,3(2):143-145. 被引量:7

二级参考文献29

  • 1王路,白雪,刘红亮,张高红,郑永唐.重组腺病毒载体vAd-tat的构建及其在细胞中的表达[J].免疫学杂志,2009(2):168-172. 被引量:7
  • 2陆瑜 叶萍 陈顺乐.白塞氏病新抗原的免疫筛选和鉴定[J].中华风湿病杂志(血管炎与风湿病专辑),2002,6:36-36.
  • 3Wainberg MA, Martinez Cajas JL. Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease [J]. Infect Disord Drug Targets, 2009, 9 (2): 172-190.
  • 4Ventoso I, Navarro J, Munoz MA, et al. Involvement of HIV-1 protease in virus-induced cell killing [J]. Antiviral Res, 2005, 66 (1):47-55.
  • 5Chaix ML, Descamps D, Wirden M, et al. Stable frequency of HIV-1 transmitted drug resistance in palients at the time of primary infection over 1996-2006 in France [J]. AIDS, 2009, 23 (6): 717-724.
  • 6Gehringer H, Von der Helm K, Seelmeir S, et al. Development and evaluation of a phenotypic assay monitoring resistance formation to protease inhibitors in HIV-1-infected patients[J]. J Virol Methods, 2003, 109 (2): 143-152.
  • 7Bartonova V, Kral V, Sieglova I, et al. Potent inhibition of drug-resistant HIV protease variants by monoclonal anti- bodies[J]. Antiviral Res, 2008, 78 (3): 275-277.
  • 8[1]Li L D, et al. Analysis of variation trend and short term detection Chinese malignant tumor mortality during twenty years. Chinese J Oncol, 1997; 19:3
  • 9[2]Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Prec Natl Acad Sci U S A.1995;92:11810
  • 10[3]Stenner F, Luo G, Sahin U, et al. Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiology, Biomarkers & Prevention.2000; 9:285

共引文献16

同被引文献45

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部